PubRank

J A Dodge

Author PubWeight™ 112.20‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Fibrosing colonopathy in cystic fibrosis: results of a case-control study. Lancet 1995 5.85
2 Infantile hypertrophic pyloric stenosis in Belfast, 1957-1969. Arch Dis Child 1975 3.44
3 Concern about records of fibrosing colonopathy study. Lancet 2001 3.27
4 Effect of storage and heat on antimicrobial proteins in human milk. Arch Dis Child 1978 2.09
5 Production of duodenal ulcers and hypertrophic pyloric stenosis by administration of pentagastrin to pregnant and newborn dogs. Nature 1970 2.00
6 Psychosomatic aspects of infantile pyloric stenosis. J Psychosom Res 1972 1.92
7 Infantile hypertrophic pyloric stenosis in South Glamorgan 1970-9. Effects of changes in feeding practice. Arch Dis Child 1983 1.78
8 Exploring self-efficacy as a predictor of disease management. Health Educ Behav 1999 1.68
9 Congenital absence of islets of Langerhans. Arch Dis Child 1977 1.65
10 Psychological determinants of infantile pyloric stenosis. Arch Dis Child 1978 1.57
11 Confidential inquiry into families with two siblings with cystic fibrosis. Arch Dis Child 1997 1.54
12 Huntington's chorea in children. Report of four cases. Neurology 1967 1.46
13 Nutrition and bronchopulmonary dysplasia. Arch Dis Child 1991 1.42
14 Induction of pyloric hypertrophy by pentagastrin. An animal model for infantile hypertrophic pyloric stenosis. Gut 1976 1.39
15 Screening for cystic fibrosis. Arch Dis Child 1982 1.33
16 Defective beta-adrenergic secretory responses in submandibular acinar cells from cystic fibrosis patients. Lancet 1986 1.23
17 Life events and family history in children with recurrent abdominal pain. J Psychosom Res 1990 1.21
18 ABO blood groups and infantile hypertrophic pyloric stenosis. Br Med J 1967 1.20
19 Studies on the mechanism of phosphatidylinositol 3-kinase inhibition by wortmannin and related analogs. J Med Chem 1996 1.18
20 Emerging therapies for the prevention or treatment of postmenopausal osteoporosis. J Med Chem 1999 1.13
21 Molecular determinants of tissue selectivity in estrogen receptor modulators. Proc Natl Acad Sci U S A 1997 1.10
22 Prostaglandin-induced diarrhoea. Arch Dis Child 1977 1.08
23 Neonatal screening for cystic fibrosis in Wales and the West Midlands: 1. Evaluation of immunoreactive trypsin test. J Clin Pathol 1988 1.08
24 Height and weight in cystic fibrosis: a cross sectional study. UK Cystic Fibrosis Survey Management Committee. Arch Dis Child 1997 1.06
25 Cystic fibrosis identified by neonatal screening: incidence, genotype, and early natural history. Arch Dis Child 1993 1.06
26 Pancreatic enzyme supplements in cystic fibrosis. Lancet 1992 1.05
27 Cutis gyratum, acanthosis nigricans and other congenital anomalies. A new syndrome. Br J Dermatol 1969 1.05
28 Orofacial granulomatosis in childhood. Br Dent J 1987 1.04
29 Oral-facial-digital syndrome. Arch Dis Child 1967 1.03
30 Recurrent abdominal pain in children. Br Med J 1976 1.00
31 Changes in functional health status of older women with heart disease: evaluation of a program based on self-regulation. J Gerontol B Psychol Sci Soc Sci 2000 0.99
32 Respiratory distress syndrome in infants of Cardiff residents during 1965-75. Br Med J 1978 0.98
33 Selective estrogen receptor modulators (SERMs). Curr Pharm Des 1998 0.96
34 Determinants of pancreatic and pulmonary status of cystic fibrosis. Lancet 1991 0.95
35 Randomised controlled trial of an aggressive nutritional regimen in sick very low birthweight infants. Arch Dis Child Fetal Neonatal Ed 1997 0.95
36 Impact of self-management education on the functional health status of older adults with heart disease. Gerontologist 1992 0.94
37 Increased energy expenditure in cystic fibrosis is associated with specific mutations. Clin Sci (Lond) 1992 0.94
38 Self-regulation of health behavior: the "take PRIDE" program. Health Educ Q 1992 0.94
39 Managing meningitis in children: audit of notifications, rifampicin chemoprophylaxis, and audiological referrals. Qual Health Care 1995 0.94
40 Shwachman-Diamond syndrome: UK perspective. Arch Dis Child 2006 0.92
41 Nature and standards of gastrointestinal and liver services in the United Kingdom. Gut 1993 0.90
42 Letter: Essential fatty acid deficiency due to artificial diet in cystic fibrosis. Br Med J 1975 0.90
43 Effect of exercise on the nasal transmucosal potential difference in patients with cystic fibrosis and normal subjects. Thorax 1994 0.89
44 Toddler diarrhoea and prostaglandins. Arch Dis Child 1981 0.89
45 Factors influencing quality of life in older women with heart disease. Med Care 2001 0.89
46 Differential effects of estrogen and raloxifene on messenger RNA and matrix metalloproteinase 2 activity in the rat uterus. Biol Reprod 2004 0.89
47 High-strength pancreatic enzyme supplements and large-bowel stricture in cystic fibrosis. Lancet 1994 0.88
48 Cystic fibrosis is no longer an important cause of childhood death in the UK. Arch Dis Child 2005 0.87
49 Aglossia-adactylia syndrome. Oral Surg Oral Med Oral Pathol 1970 0.86
50 Survival estimates for adults with cystic fibrosis born in the United Kingdom between 1947 and 1967. The UK Cystic Fibrosis Survey Management Committee. Thorax 1999 0.86
51 Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency--diagnosis, plasma carnitine fractions and management in a further patient. Eur J Pediatr 1993 0.85
52 Effects of an artificial diet on growth of patients with cystic fibrosis. Arch Dis Child 1978 0.85
53 Gender differences in the associations of self esteem, stress and social support with functional health status among older adults with heart disease. J Women Aging 2001 0.85
54 Two cases of trisomy D associated with adrenal tumours. J Med Genet 1972 0.85
55 Gastrointestinal tract and nutrition in cystic fibrosis: pathophysiology. J R Soc Med 1986 0.84
56 The children's Life Events Inventory. J Psychosom Res 1979 0.84
57 Managing heart disease: a study of the experiences of older women. J Am Med Womens Assoc 1995 0.84
58 Cystic fibrosis serum stimulates mucin secretion but not calcium efflux from rat submandibular acini. Clin Chim Acta 1983 0.84
59 Accidents in childhood. Ulster Med J 1966 0.83
60 Adrenergic secretory responses of submandibular tissues from control subjects and cystic fibrosis patients. Clin Chim Acta 1985 0.83
61 Rat small intestinal morphology and tissue regulatory peptides: effects of high dietary fat. Br J Nutr 1991 0.83
62 Proceedings: Maternal factor in infantile hypertrophic pyloric stenosis. Arch Dis Child 1974 0.83
63 The nongenotropic synthetic ligand 4-estren-3alpha17beta-diol is a high-affinity genotropic androgen receptor agonist. Mol Pharmacol 2004 0.83
64 Screening for cystic fibrosis. Br Med Bull 1992 0.82
65 Comparison between a standard pancreatic supplement and a high enzyme preparation in cystic fibrosis. Aliment Pharmacol Ther 1992 0.81
66 The nutritional state and nutrition. Acta Paediatr Scand Suppl 1985 0.80
67 Zinc deficiency syndrome in a British youth with cystic fibrosis. Br Med J 1978 0.80
68 Letter: Heterozygote advantage in cystic fibrosis. Lancet 1975 0.80
69 Incidence of molecular forms of bile salt-stimulated lipase in preterm and term human milk. Pediatr Res 1998 0.80
70 Gluten intolerance, gluten enteropathy, and coeliac disease. Arch Dis Child 1980 0.80
71 Oral rehydration without added bicarbonate for childhood gastroenteritis. Br Med J (Clin Res Ed) 1984 0.79
72 Stated versus actual lipase activity in pancreatic enzyme supplements: implications for clinical use. J Pediatr Gastroenterol Nutr 1995 0.79
73 The selective oestrogen receptor modulator, LY362321, is not neuroprotective in a rat model of transient focal ischaemia. J Neuroendocrinol 2008 0.78
74 Hereditary gingival fibromatosis. J Ment Defic Res 1971 0.78
75 Essential fatty acid deficiency after prolonged treatment with elemental diet. Lancet 1980 0.78
76 The influence of nutrition on neonatal respiratory muscle function. Intensive Care Med 1992 0.78
77 The impact of a disease-management program on the symptom experience of older women with heart disease. Women Health 1999 0.78
78 Abnormal distribution of ABO blood groups in infantile pyloric stenosis. J Med Genet 1971 0.77
79 Gene/energy interaction in cystic fibrosis. Lancet 1990 0.77
80 Toddler diarrhoea: observations on the effects of aspirin and loperamide. J Pediatr Gastroenterol Nutr 1985 0.77
81 Modulation of fluid absorption and the secretory response of rat jejunum to cholera toxin by dietary fat. Gut 1990 0.77
82 Effects of wortmannin analogs on bone in vitro and in vivo. J Pharmacol Exp Ther 1996 0.77
83 Exudate variation in the rabbit gastrointestinal tract: a scanning electron microscope study. J Anat 1990 0.76
84 Gastrin, somatostatin and infantile hypertrophic pyloric stenosis. Acta Paediatr 2001 0.76
85 A complex biochemical modulation of intestinal ion transport in rats fed on high-fat diets. J Pediatr Gastroenterol Nutr 1995 0.76
86 Campylobacter pylori and reflux oesophagitis. Acta Paediatr Scand 1990 0.76
87 Biochemical basis of cystic fibrosis. Nature 1986 0.76
88 Confusion surrounding nitric oxide synthase/NADPH-diaphorase. J Pediatr Gastroenterol Nutr 1996 0.75
89 Factors associated with chronic lung disease in preterm infants. Arch Dis Child 1992 0.75
90 Antiviral and antibacterial lipids in human milk and infant formula. Arch Dis Child 1991 0.75
91 Peptic ulceration and phenylketonuria: a possible link? Gut 1988 0.75
92 Electronmicroscopy in 'absence' of islets of Langerhans in a newborn infant. Arch Dis Child 1982 0.75
93 Letter: Changing incidence of congenital pyloric stenosis. Br Med J 1974 0.75
94 Study of breast feeding and hypertrophic pyloric stenosis does not conflict with others. BMJ 1996 0.75
95 Gene therapy for cystic fibrosis. Nat Med 1995 0.75
96 Systemic Haemophilus influenzae and facial cellulitis in infants. Br Med J (Clin Res Ed) 1981 0.75
97 Low butanol-extractable-iodine levels in the serum of patients with Down's syndrome. Lancet 1967 0.75
98 Neonatal screening for cystic fibrosis. Cystic fibrosis should be added to diseases sought in all newborn babies. BMJ 1998 0.75
99 Letter: Essential fatty acids in cystic fibrosis. Arch Dis Child 1975 0.75
100 A case of sarcoid arthritis in a child. Ann Rheum Dis 1983 0.75
101 Further observations on a pedigree of the oral-facial-digital syndrome. Arch Dis Child 1969 0.75
102 Provision of health care for cystic fibrosis. J R Soc Med 1987 0.75
103 Dietary fat in cystic fibrosis. J Pediatr 1994 0.75
104 Gene therapy for cystic fibrosis: what message for the recipient? Thorax 1998 0.75
105 Kinetics of viral replication in experimental rotavirus infection: effects of high dietary fat. J Pediatr Gastroenterol Nutr 1991 0.75
106 OFD syndrome. Arch Dis Child 1970 0.75
107 Further comments on fibrosing colonopathy study. Lancet 2001 0.75
108 With commentary. Arch Dis Child 1980 0.75
109 Screening for cystic fibrosis. Arch Dis Child 1983 0.75
110 Duodenal bile acids in diagnosis of congenital biliary atresia. J Pediatr Surg 1983 0.75
111 Pyloric stenosis and eosinophilic gastroenteritis in infants. J Pediatr Gastroenterol Nutr 1988 0.75
112 Comparison of three regimens in the management of acute gastroenteritis in infants. Aliment Pharmacol Ther 1990 0.75
113 Infantile pyloric stenosis inheritance, psyche and soma. Ir J Med Sci 1973 0.75
114 Analyzing nurse-client interactions in family planning clinics. J Community Health Nurs 1989 0.75
115 Neonatal pyloric hypertrophy and duodenal ulceration produced by pentagastrin. Gut 1969 0.75
116 Colonic wall thickness and pancreatic enzymes in cystic fibrosis. Arch Dis Child 1999 0.75
117 HLA types and ABO blood groups in infants with pyloric stenosis and their mothers. Tissue Antigens 1976 0.75
118 Surface features of small-intestinal mucosa in childhood diarrheal disorders. J Pediatr Gastroenterol Nutr 1996 0.75
119 Neonatal infection does not affect the immunoreactive trypsinogen screening test for cystic fibrosis. J Pediatr Gastroenterol Nutr 1994 0.75
120 Prostaglandins and cystic fibrosis. Monogr Paediatr 1979 0.75
121 Pycnodysostosis. Dev Med Child Neurol 1969 0.75
122 Treatment of hypernatraemic dehydration due to diarrhoea. Br J Clin Pract 1986 0.75
123 Theophylline inhibits platelet aggregation, prostaglandin and thromboxane production by a mechanism which is independent of cyclic AMP. Agents Actions 1984 0.75
124 Dietary management of cystic fibrosis. Practitioner 1981 0.75
125 The effects of high fat diet on ionic transport in rat intestine. Biochem Soc Trans 1991 0.75
126 Development of analytical and preparative chromatographic separations of novel growth hormone secretagogue compounds. J Chromatogr A 2000 0.75
127 Short stature and malnutrition in cystic fibrosis. Lancet 1989 0.75
128 Energy content of breast milk of poor Brazilian mothers. Lancet 1984 0.75
129 Infantile hypertrophic pyloric stenosis. Nurs Times 1977 0.75
130 Proceedings: Absence of islets of Langerhans in pancreas of a newborn. Arch Dis Child 1975 0.75
131 Familial craniosynostosis with oral anomalies. Dev Med Child Neurol 1970 0.75
132 Screening for cystic fibrosis: why, how, and when? Pediatr Pulmonol Suppl 1991 0.75
133 Diagnostic criteria for coeliac disease and transient gluten intolerance. Lancet 1980 0.75
134 CF or not CF? That is the question. J Cyst Fibros 2002 0.75
135 Effectiveness of counselling in cystic fibrosis. Patient Couns Health Educ 1978 0.75
136 Fat and energy content of breast milk of malnourished and well nourished women, Brazil 1982. Ann Trop Paediatr 1985 0.75
137 Abnormal levels of prostaglandins and fatty acids in cystic fibrosis. Lancet 1978 0.75